• English
    • español
    • português (Brasil)
  • English 
    • English
    • español
    • português (Brasil)
  • Login
Search 
  •   COVID-19
  • Search
  •   COVID-19
  • Search
JavaScript is disabled for your browser. Some features of this site may not work without it.

Search

Show Advanced FiltersHide Advanced Filters

Filters

Use filters to refine the search results.

Now showing items 1-6 of 6

  • Sort Options:
  • Relevance
  • Title Asc
  • Title Desc
  • Issue Date Asc
  • Issue Date Desc
  • Results Per Page:
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
  • Thumbnail

    A Multi-centre, Adaptive, Randomized, Double-Blind, PlaceboControlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients 

    World Health Organization
    This is a multi-centre, adaptive, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of investigational therapeutic agents in combination with standard-of care for the treatment ...
  • Thumbnail

    COVID-1. Informal consultation on the potential role of chloroquine in the clinical management of COVID 19 infection, draft 13 March 2020 

    World Health Organization (2020-03-13)
    Currently, there are no therapeutic agents licensed and available for the treatment of COVID 19. On the 27th of January, WHO convened a meeting of experts to examine the available evidence and prioritize promising therapeutic ...
  • Thumbnail

    Off-label use of medicines for COVID-19. Scientific brief, 31 March 2020 

    World Health Organization (2020-03-31)
    No pharmaceutical products have yet been shown to be safe and effective for the treatment of COVID-19. However, a number of medicines have been suggested as potential investigational therapies, many of which are now being ...
  • Thumbnail

    Assessment tool for laboratories implementing COVID-19 virus testing. Interim guidance, 8 April 2020 

    World Health Organization (2020-04-08)
    Background: This tool has been designed to assess the capacity of laboratories that have implemented or intend to implement testing for SARS-CoV-2, the virus that causes novel coronavirus disease 2019 (COVID-19). The tool ...
  • Thumbnail

    The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19. Scientific Brief, 19 April 2020 

    World Health Organization (2020-04-18)
    Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used drugs, and have a wide range of uses. NSAIDs include nonselective cyclooxygenase (COX) inhibitors (such as ibuprofen, aspirin ...
  • Thumbnail

    Technical specifications for Pressure Swing Adsorption(PSA) Oxygen Plants, 8 June 2020 

    World Health Organization (2020-06-08)
    Oxygen is an essential medicine required at all levels of the health care system; only high quality, medical-grade oxygen should be given to patients. Pressure swing adsorption (PSA) oxygen generating plants are a source ...

Discover

Category
Candidate therapeutics RD (6)
Infection prevention and control, including health care workers protection (1)LanguageEnglish (3)TypeWHO / PAHO Guidance (4)Research protocol information (2)Author
World Health Organization (6)
SubjectCoronavirus (4)COVID-19 (4)Infectious Diseases (4)Anti-Inflammatory Agents, Non-Steroidal (1)Medicines (1)Pressure Swing Adsorption (PSA) (1)Reagent Kits, Diagnostic (1)Research (1)SARS-CoV (1)... View MoreDate Issued2020 (5)CountryGlobal (WHO/OMS) (6)

Browse

AllCommunities & CollectionsBy Issue DateAuthorsTitlesCategorySubjects

My Account

LoginRegister

Pan American Health Organization
World Health Organization. Regional Office for the Americas
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America

Content Disclaimer (Important notes about the material)

Links

  • WHO International Clinical Trial Registry Platform (ICTRP)
  • WHO Coronavirus disease R&D Blueprint
  • WHO Database of Publications on Coronavirus Disease
  • PAHO Coronavirus Disease
  • PAHO/BIREME Windows of Knowledge COVID-19
  • Evidence aid Coronavirus (COVID-19) resources

  • PAHO Digital Library (IRIS PAHO)
  • Virtual Health Library (VHL)
  • Global Index Medicus (GIM)